secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001104659-24-085198
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

NW Bio investigates social media rumors; MHRA MAA review continues
------------------------------------------------------------------

- Company probing rumors linked to parties in federal NY lawsuit; coinciding with stock market developments.
- Plans to pursue appropriate action against rumor sources; shareholders asked to report information.
- MHRA review of Marketing Authorization Application in UK ongoing; inspections scheduled in US and UK.
- CEO Linda Powers signed the disclosure; no financial guidance or earnings data provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/0001104659-24-085198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924085198/tm2420750d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-085198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer